← Leaderboards
John M Coffin
Miriam Hospital
$22,688,280
Attributed
$22,688,280
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$22,688,280 · 8
By mechanism
R35$7,366,600 · 2
R37$6,538,090 · 1
R01$6,348,708 · 3
P30$2,434,882 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Retroviridae”
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Ellis L Reinherz · Dana-Farber Cancer Institute$16,769,846
- Tatyana V. Golovkina · Jackson Laboratory$16,114,627
- John M. Sedivy · Brown University$12,925,113
- Edmundo Nelson Kraiselburd · University Of Puerto Rico Med Sciences$11,669,600
- Hans-Peter Kiem · Fred Hutchinson Cancer Center$10,916,471
Research focus
RetroviridaeEvolutionBiologyVirus ReplicationCellsProvirusesAcquired Immunodeficiency SyndromeFundingVirusReceptorProgramsPrimatesInterestProvirusResearch SupportExhibitsBaseInnovationGenomeResearch PersonnelDrug ResistanceVirus GeneticsMutantMember
Grant awards (56)
Human endogenous provirus inhibition of HIV replication$694,319
R01 · FY2025 · AI · contact PI
Human endogenous provirus inhibition of HIV replication$715,794
R01 · FY2024 · AI · contact PI
Retrovirus Evolution and Cancer$922,751
R35 · FY2022 · CA · contact PI
Retrovirus Evolution and Cancer$799,783
R35 · FY2021 · CA · contact PI
Retrovirus Evolution and Cancer$899,061
R35 · FY2020 · CA · contact PI
Retrovirus Evolution and Cancer$939,255
R35 · FY2019 · CA · contact PI
Retrovirus Evolution and Cancer$921,749
R35 · FY2018 · CA · contact PI
Retrovirus Evolution and Cancer$977,972
R35 · FY2017 · CA · contact PI
Developmental$168,238
P30 · FY2017 · AI · contact PI
Retrovirus Evolution and Cancer$990,000
R35 · FY2016 · CA · contact PI
Developmental$375,748
P30 · FY2016 · AI · contact PI
Retrovirus Evolution$672,457
R37 · FY2015 · CA · contact PI
Developmental$316,488
P30 · FY2015 · AI · contact PI
Retrovirus Evolution$652,285
R37 · FY2014 · CA · contact PI
Retrovirus Evolution$632,109
R37 · FY2013 · CA · contact PI
Retrovirus Evolution$672,458
R37 · FY2012 · CA · contact PI
Retrovirus Evolution$672,456
R37 · FY2011 · CA · contact PI
Developmental$252,130
P30 · FY2011 · AI · contact PI
Retrovirus Evolution$666,343
R37 · FY2010 · CA · contact PI
Developmental$379,642
P30 · FY2010 · AI · contact PI
Retrovirus Evolution$655,902
R37 · FY2009 · CA · contact PI
Developmental$249,210
P30 · FY2009 · AI · contact PI
Retrovirus Evolution$639,885
R37 · FY2008 · CA · contact PI
Developmental$221,222
P30 · FY2008 · AI · contact PI
Retrovirus Evolution$635,763
R37 · FY2007 · CA · contact PI
Developmental$249,756
P30 · FY2007 · AI · contact PI
Retrovirus Evolution$638,432
R37 · FY2006 · CA · contact PI
Characterization of the Genetic Diversity of HIV-1 in In$0
Z01 · FY2006 · BC · contact PI
Characterization of the Genetic Diversity of HIV-1 in In$0
Z01 · FY2006 · BC · contact PI
Investigation of Persistent Viremia in Patients on Antir$0
Z01 · FY2006 · BC · contact PI
HIV Genetic Variation in HIV-Infected Individuals$0
Z01 · FY2006 · BC · contact PI
RETROVIRUS EVOLUTION$616,568
R01 · FY2005 · CA
Integration and Expression of Retrovirus DNA$396,250
R01 · FY2005 · CA
In Vivo Assessment of Residual Drug Activity in Patients$0
Z01 · FY2005 · BC
Characterization of the Genetic Diversity of HIV-1 in In$0
Z01 · FY2005 · BC
Investigation of the Nature of Persistent Viremia (50 co$0
Z01 · FY2005 · BC
RETROVIRUS EVOLUTION$623,155
R01 · FY2004 · CA
Integration and Expression of Retrovirus DNA$396,250
R01 · FY2004 · CA
In Vivo Assessment of Residual Drug Activity in Patients$0
Z01 · FY2004 · BC
Characterization of the Genetic Diversity of HIV-1 in In$0
Z01 · FY2004 · BC
RETROVIRUS EVOLUTION$586,690
R01 · FY2003 · CA
Integration and Expression of Retrovirus DNA$396,250
R01 · FY2003 · CA
In Vivo Assessment of Residual Drug Activity in Patients$0
Z01 · FY2003 · BC
Characterization of the Genetic Diversity of HIV-1$0
Z01 · FY2003 · BC
RETROVIRUS EVOLUTION$572,402
R01 · FY2002 · CA
Integration and Expression of Retrovirus DNA$396,250
R01 · FY2002 · CA
Population Dynamics, Genetics, and Evolution of Retrovir$0
Z01 · FY2002 · BC
RETROVIRUS EVOLUTION$558,530
R01 · FY2001 · CA
Integration and Expression of Retrovirus DNA$396,250
R01 · FY2001 · CA
CORE--DEVELOPMENTAL$129,540
P30 · FY2001 · AI
Population Dynamics, Genetics, and Evolution of Retrovir$0
Z01 · FY2001 · BC
CORE--DEVELOPMENTAL$0
P30 · FY2001 · AI
MOLECULAR BIOLOGY OF RETROVIRUSES$883,885
R35 · FY2000 · CA
CORE--DEVELOPMENTAL$92,908
P30 · FY2000 · AI
MOLECULAR BIOLOGY OF RETROVIRUSES$32,144
R35 · FY2000 · CA
Population Dynamics, Genetics, Evolution of Retroviruses$0
Z01 · FY2000 · BC